---
$id: https://graph.org.ai/products/commodity/51142421
$type: Product
source: UNSPSC
code: "51142421"
title: "Naratriptan"
class: "51142400"
classTitle: "Drugs used for vascular and migraine headaches"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Naratriptan

**UNSPSC Code**: 51142421
**Class**: [Drugs used for vascular and migraine headaches](Drugs used for vascular and migraine headaches.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin agonist with the molecular formula C17H25N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QX3KXL1ZA2, chemically known as 1h-indole-5-ethanesulfonamide, n-methyl-3-(1-methyl-4-piperidinyl)- but generally known as naratriptan, which bears US NIH Compound Identifier 4440. European Medicines Agency schedules Naratriptan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09164MIG. The term NARATRIPTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). World Health Organization schedules naratriptan in its Anatomical Therapeutic Chemical (ATC) Classification. NARATRIPTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naratriptan under HS 29350090 and SITC 51580. As of Q4 2014, NARATRIPTAN remains the US FDA Preferred Term for this commodity. Naratriptan bears US NLM identifiers UMLS ID C0540623 and NCI Concept Code C61857. SMILES: S(=O)(=O)(NC)CCC1CC2C(C3CCN(CC3)C)C[NH]C2CC1.

